Kleenlac

Kleenlac Syrup

Galactose

NABIQASIM INDUSTRIES (PVT) LTD.

Drug Identity

Active Ingredient
Galactose
Drug Class
Drugs For Constipation
Chemical Class
Gadolinium
0

What is Kleenlac?

Uses
Galactose Microparticles is a monosaccharide. It is used to enhance ultrasound images of heart or female genital tract and as a measure o...

How It Works

Chemical Class
Gadolinium

It belongs to Gadolinium. It belongs to Ultrasound Contrast Media pharmacological group. The Molecular Weight of Galactose Microparticles is 547.60. It is weakly acidic drug, 4.92% solution of the drug is isotonic.

How to Take It

1
Adult · IV
7.196 to 17.989 mg/kg — As recommended.
As Required
2
Child · Intra Venous
0.2 mg/kg — As recommended.
As Required

Safety Alerts

Galactosaemia, intestinal obstruction

Important Warnings

Lactose intolerance, patients on low galactose diet,

Side Effects

Hypokalemiahyponatremiadehydrationflatulencediarrhoeanauseavomitingabdominal paincrampsbloating.

Drug Interactions

No data regarding the interactions of Galactose Microparticles was found.

Pregnancy & Lactation

Pregnancy
Caution advised
Lactation
Caution advised

Storage

Susp Store in a well closed container, Below 40°C.

Price Intelligence

Rs 305.68
DRAP approved maximum price · per 120ml · approved 23 Jul, 2026
No retail price observed for this pack. Retailers may not exceed the approved maximum.
Prices across sources
DRAPper 120mlRs 305.68

Should you consider an alternative?

Other options containing Galactose, and what they are not.

These contain this ingredient plus others. They are different medicines — do not swap.

Ordered by lowest price per unit where a pack size is known, then by price. Order is never affected by sponsorship. Not medical advice — confirm any change with your pharmacist or doctor.

For pharma professionalsCompany, market and opportunity intelligence

Company

Prices as of 30 July 2026 · DRAP ceiling as of 30 July 2026 · schema v3-SKU

For medicine intelligence and professional reference only. Not medical advice.